v3.26.1
DECONSOLIDATION OF SUBSIDIARIES (Details Narrative) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Restructuring Cost and Reserve [Line Items]    
Loss (gain) from deconsolidation of OBI, Korea and Belgium subsidiaries in 2024 (Octomera in 2023) $ (4,480) $ 5,343
Related Party [Member]    
Restructuring Cost and Reserve [Line Items]    
Accounts payable related parties 2,695 $ 133
Orgenesis Biotech Israel Limited [Member]    
Restructuring Cost and Reserve [Line Items]    
Loss (gain) from deconsolidation of OBI, Korea and Belgium subsidiaries in 2024 (Octomera in 2023) 66  
Orgenesis Biotech Israel Limited [Member] | Related Party [Member]    
Restructuring Cost and Reserve [Line Items]    
Accounts payable related parties 2,695  
Orgenesis Korea [Member]    
Restructuring Cost and Reserve [Line Items]    
Loss (gain) from deconsolidation of OBI, Korea and Belgium subsidiaries in 2024 (Octomera in 2023) 1,335  
Orgenesis Belgium SRL And Orgenesis SRL [Member]    
Restructuring Cost and Reserve [Line Items]    
Loss (gain) from deconsolidation of OBI, Korea and Belgium subsidiaries in 2024 (Octomera in 2023) $ 3,213